John Moore，這個(gè)細(xì)胞系的來源患者（取樣時(shí)33歲），起訴David Golde和加利福尼亞大學(xué)，因?yàn)樗麄儧]有經(jīng)John Moore的許可在Mo細(xì)胞系上申請了專利。盡管摩爾的所有權(quán)主張?jiān)獾骄芙^，但他的醫(yī)生卻被認(rèn)為違反了他的受托責(zé)任。 在本庫通過支原體檢測。 在本庫通過STR檢測。

形態(tài)：淋巴母細(xì)胞；懸浮生長

培養(yǎng)基配方：

90%1640(MD0200)+10%胎牛血清(SD0200)+G/A (SD0038)

完全培養(yǎng)基：1640完全培養(yǎng)基（MD0201）

氣相：空氣，95%；二氧化碳，5%。 溫度：37℃。

凍存條件：基礎(chǔ)培養(yǎng)基+5%DMSO+20%FBS　

完全凍存液：免程序降溫細(xì)胞凍存液（低血清）(SD0001)

聲明：產(chǎn)品僅科研使用。

PubMed=305224; DOI=10.7326/0003-4819-88-3-323

Saxon A., Stevens R.H., Golde D.W.

T-lymphocyte variant of hairy-cell leukemia.

Ann. Intern. Med. 88:323-326(1978)

PubMed=6984393

Gauwerky C.E., Lusis A.J., Golde D.W.

Erythroid-potentiating activity: characterization and target cells.

Exp. Hematol. 8 Suppl. 8:117-127(1980)

PubMed=6987658; DOI=10.1073/pnas.77.1.593

Golde D.W., Bersch N., Quan S.G., Lusis A.J.

Production of erythroid-potentiating activity by a human T-lymphoblast cell line.

Proc. Natl. Acad. Sci. U.S.A. 77:593-596(1980)

PubMed=6600440; DOI=10.1007/BF02617996

Uittenbogaart C.H., Cantor Y., Fahey J.L.

Growth of human malignant lymphoid cell lines in serum-free medium.

In Vitro 19:67-72(1983)

Patent=US4438032

Golde D.W., Quan S.G.

Unique T-lymphocyte line and products derived therefrom.

Patent number US4438032, 20-Mar-1984

CLPUB00468

Javitt G.

Why not take all of me? Reflections on the immortal life of Henrietta Lacks and the status of participants in research using human specimens.

Minn. J. Law Sci. Technol. 11:713-755(2010)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017

Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

A landscape of pharmacogenomic interactions in cancer.

Cell 166:740-754(2016)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747

Dutil J., Chen Z., Monteiro A.N., Teer J.K., Eschrich S.A.

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Cancer Res. 79:1263-1273(2019)